| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5956484 | Chest | 2012 | 10 Pages |
Abstract
PL2 was a significant prognostic factor for recurrence and worse overall survival in node-negative NSCLC with VPI. This information is important for further design of clinical trials for aggressive adjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jung-Jyh MD, PhD, Wen-Juei MD, Wen-Hu MD, Teh-Ying MD, PhD, Shiou-Fu MD, Yu-Chung MD,